Serzone Drug Labeling Changes

Recent reports of liver damage and/or failure in patients taking the prescription antidepressant Serzone prompted the FDA to require a black box warning for the drug. In addition to the black box warning, other changes were made in the labeling. Click below to read more.

http://www.fda.gov/medwatch/SAFETY/2002/serzone_label.pdf

Attorney Search

Find a Serzone attorney.

Serzone

News Alert

We will email you a news alert when a Serzone news article appears online.

Serzone Questions

To learn more about the Serzone, its side effects or to contact an attorney, please fill out the form below.